Monday, 5 September 2016
Morning
Biopharmaceutical manufacturing and single-use technologies: Update about latest achievements
| 09:00 - 09:30 | Registration and coffee |
| Session chair | Cathy Kroll, Swiss Biotech Association |
| 09:30 - 09:50 | Welcome Message Jean-Marc Piveteau, Zurich University of Applied Sciences, Switzerland |
| 09:50 - 10:20 | Current trends in single-use technologies: How future SUS developments will affect therapeutics and biosimilars productions over the next 5 years Eric Langer, BioPlan Associates |
| 10:20 - 10:50 | Making drugs more affordable: Smart design & implementation of fully single-use bioprocess platforms & facilities for mAb’s, ADC’s & vaccines: client case studies Miriam Monge, Sartorius Stedim Biotech |
| 10:50 - 11:20 | Modular facility & flexible manufacturing platform solutions for modern single-use based biomanufacturing Robert Morenweiser, GE Healthcare |
| 11:20 - 13:00 | Lunch, exhibition and poster session |
Noon, Parallel session 1
Novel developments in applications with mammalian, insect and microbial cells
| Session chair | Ralf Pörtner, Technical University Hamburg |
| 13:00 - 13:25 | Reinventing commercial biomanufacturing Sarfaraz K. Niazi, Therapeutic Proteins International |
| 13:25 - 13:50 | Breakthrough from the developer`s perspective Klaus Kaiser, Bayer Pharma |
| 13:50 - 14:15 | Bioreactor options for continuous cell culture-derived viral vaccine production: less defective interfering particles through process intensification Yvonne Genzel, Felipe Tapia, Daniel Vazquez, Ilona Behrendt, Ingo Jordan, J. Gangemi, Udo Reichl, Max Planck Institute Magdeburg, Timothy Bürgin, Kühner AG |
| 14:15 - 14:40 | Increasing efficiency of insect cell-based vaccine production processes Ina Dittler and Regine Eibl, ZHAW |
| 14:40 - 15:05 | The influence of bisphenol A (BPA) on mammalian cell cultivation Iris Pavenstädt, Thermo Fisher Scientific |
| 15:05 - 15:35 | Coffee break and exhibition |
Noon, Parallel session 2
Implementation of single-use technologies in the development and production of cell- and gene therapeutics
| Session chair | Regine Eibl, ZHAW |
| 13:00 - 13:25 | Applying concepts of mAbs and vaccines development and manufacturing to cellular immune therapy Alain Pralong, Cell Medica Ltd. |
| 13:25 - 13:50 | Commercial manufacture of cell therapeutics: Status and path forward Christian van den Bos, Mares Ltd. |
| 13:50 - 14:15 | GMP production of immune cells as ATMPs with Novel Technology Christian Leschke, Shreemanta K. Parida, Evguenyi Sinelnikow, Hans Hoffmeister, Zellwerk GmbH, Germany |
| 14:15 - 14:40 | Single-use technologies in hMSC and iPSC productions: Status quo and future needs Erika M. McAfee, Lonza Inc. |
| 14:40 - 15:05 | Scaling microcarrier-based expansion processes for production of high quality cells Mark Szczypka, Pall Life Sciences |
| 15:05 - 15:35 | Coffee break and exhibition |
Afternoon, Parallel session 1
Novel developments in applications with mammalian, insect and microbial cells
| Session chair | Rainer Glöckler, Swissfillon |
| 15:35 - 16:00 | Single-use technology for microbial processes: Potentials and challenges Peter Neubauer, Anna Maria Marbà Ardébol, Olivia Zakrzewski, Stefan Junne, Technical University Berlin |
|
16:00 - 16:25 |
Finding the missing link in complete single-use fermentation line: Evaluation of single-use large scale systems for aerobic bacteria Nicolas Chaudet, Grégoire Exbrayat, Marjorie Monnet, Jean-Marc Guillaume, Bioprocess R&D Sanofi Pasteur |
| 16:25 - 16:50 | A simple model-based strategy for microbial process design in single-use bioreactors Patrick Sagmeister, Valentin Steinwandter, Thomas Zahel Exputec Vienna, Sophia Ulonska, Christoph Herwig, Vienna University of Technology |
| 16:50 - 17:15 | Single-use fermentation: Understanding process economy and process performance Angus Thompson, Fujifilm Diosynth, and Sebastian Rothe, GE Healthcare |
| 17:15 - 17:40 | Heat characteristics of stirred single-use bioreactors Matthias Müller, Wolfram Meusel, Anhalt University of Applied Sciences, Ute Husemann, Gerhard Greller, Sartorius Stedim Biotech |
| 17:40 - 18:45 | Exhibition and poster session |
| 19:30 | Conference dinner (boat trip on Lake Zurich) |
Afternoon, Parallel session 2
Implementation of single-use technologies in the development and production of cell- and gene therapeutics
| Session chair | Daniel Gygax, NTN Swiss Biotech |
| 15:35 - 16:00 | Novartis cell & gene therapy Christian Leist, Novartis Cell & Gene Therapy |
| 16:00 - 16:25 | Manufacturing of natural killer cell products for clinical applications Volker Huppert, Miltenyi Biotec GmbH |
| 16:25 - 16:50 | Building the T cell factory of the future Clive Glover, GE Healthcare Life Sciences |
| 16:50 - 17:15 | How to use Computational Fluid Dynamics in the development of cell therapeutics Valentin Jossen, Dieter Eibl, ZHAW, and Matthias Kraume, Technical University Berlin |
| 17:15 - 17:40 | Evaluation of Eppendorf BioBLU single-use bioreactors for cell and stem cell culture and scale-up Sebastian Kleebank, Bin Li, Muriel Art, Kevin Han, Amanda Suttle, Francoise Delongueville, Stacey Willard, Ma Sha, Eppendorf Germany, USA and Belgium |
| 17:40 - 18:45 | Exhibition and poster session |
| 19:30 | Conference dinner (boat trip on Lake Zurich) |
Online registration for the conference will be open until 29th August 2016.